O'Hanlon J J, Muldoon T, Lowry D, McCleane G
Department of Anaesthetics, Craigavon Area Hospital, Portadown.
Can J Anaesth. 1996 Feb;43(2):102-5. doi: 10.1007/BF03011248.
Piroxicam like other Non-Steroidal Anti-Inflammatory drugs can be used to provide postoperative analgesia. With a half-life of 50 hr given preoperatively its' analgesic effect should continue postoperatively. This study compared the effects of 20 mg piroxicam given at different times in the perioperative period on postoperative analgesic requirement.
Following ethical committee approval and written informed consent, 60 ASA I and II patients presenting for inpatient gynaecological laparoscopic surgery were given either 20 mg piroxicam or a placebo po two hours preoperatively, immediately before induction of anaesthesia or one hour postoperatively in a randomised double bind manner.
Postoperative Visual Analogue Pain Scores were lower on admission to the recovery ward in patients given piroxicam preoperatively (Group 1), than in the other two treatment groups (groups 2 and 3). Pain scores were 2.72 vs 4.25 vs 6.67 respectively (P < 0.001). Pain scores did not differ at any other times. Time to first analgesic request was greater in the group 1 than in the other two treatment groups; 141 (61) min vs 115 (147) in Group 2 and 30 (36) min in Group 3. Nine patients in Group 1 requested further analgesia compared with 15 in Group 2 and 16 in Group 3. There were no piroxicam-induced side-effects.
Piroxicam given two hours preoperatively reduced pain scores, time to first analgesia and postoperative analgesic requirements compared with administration prior to induction or one hour postoperatively.
吡罗昔康与其他非甾体类抗炎药一样,可用于术后镇痛。术前给予其半衰期为50小时,术后镇痛效果应能持续。本研究比较了围手术期不同时间给予20毫克吡罗昔康对术后镇痛需求的影响。
经伦理委员会批准并获得书面知情同意后,60例拟行住院妇科腹腔镜手术的ASA I级和II级患者,以随机双盲方式在术前两小时、麻醉诱导前即刻或术后一小时口服20毫克吡罗昔康或安慰剂。
术前给予吡罗昔康的患者(第1组)进入恢复病房时的术后视觉模拟疼痛评分低于其他两个治疗组(第2组和第3组)。疼痛评分分别为2.72、4.25和6.67(P<0.001)。其他时间的疼痛评分无差异。第1组首次镇痛请求时间比其他两个治疗组更长;第1组为141(61)分钟,第2组为115(147)分钟,第3组为30(36)分钟。第1组有9例患者需要进一步镇痛,第2组为15例,第3组为16例。未出现吡罗昔康引起的副作用。
与麻醉诱导前或术后一小时给药相比,术前两小时给予吡罗昔康可降低疼痛评分、首次镇痛时间和术后镇痛需求。